冠心病稳定型心绞痛患者MPO及MMP-9表达变化(3)
 |
| 第1页 |
 |
| 第6页 |
参见附件(3186KB，7页)。
[3] Gensini GG.A more meaningful scoring system for determining the severity of coronary heart disease[J].Am J Cardiol,1983,51(3):606.
[4] Foster CB,Lehrnbecher T,Mol F,et al.Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease [J].J Clin Invest,1998,102(12):2146-2155.
[5] Sugiyama S,Kugiyama K,Alikawa M,et al.Hypochlorous acid,a macrophage product,induces endothelial apoptosis and tissue factor expression:Involvement of myeloperoxidase-mediated oxidant in plaque erosion and thrombogenesis [J].Arterioscler Thromb Vasc Biol,2004,24(7):1309-1314.
[6] Hazen SL,Crowley JR,Mueller DM,et al.Mass spectrometric quantification of 3-chlorotyrosine in human tissues with attomole sensitivity:A sensitive and specific marker for myeloperoxidase-catalyzed chlorination at sites of inflammation[J].Free Radic Biol Med,1997,23(6):909-916.
[7] Baldus S,Heeschen C,Meinertz T,et al.Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes[J].Circulation,2003,108(12):1440-1445.
[8] Brennan ML,Penn MS,Van Lente F,et al.Prognostic value of myeloperoxidase in patients with chest pain[J].N Engl J Med,2003,349(17):1595-1604.
[9] 曹平良，葛郁芝，盛国泰，等.髓过氧化物酶和超敏C反应蛋白在冠心病中的对比研究[J].中国心血管病研究杂志,2005,3(9):651-652.
[10] Brennan ML,Penn MS,Van Lente F,et al.Prognostic value of myeloperoxidase in patients with chest pain[J].N Engl J Med,2003,349(17):1595-1604.
[11] 刘志远，张金盈，李纲，等.髓过氧化物酶与冠心病患者冠状动脉病变程度的关系[J].中国医药导刊,2007,9(6):451-452.
[12] 欧阳茂,杨侃,张梦玺,等.血浆髓过氧化物酶在急性冠脉综合征中的临床意义[J].中南大学学报(医学版),2006,31(6):901-905.
[13] Nikpoor B,Turecki G,Fouminer C,et al ......
您现在查看是摘要介绍页，详见PDF附件(3186KB，7页)。